CI Investments Inc
EDIT icon

CI Investments Inc’s Editas Medicine EDIT Stock Holding History

CI Investments Inc’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,222
Closed -$83K – 1274
2024
Q1 		$83K Buy
11,222
+9
+0.1% +$75 ﹤0.01% 934
2023
Q4 		$114K Buy
11,213
+543
+5% +$4.77K ﹤0.01% 802
2023
Q3 		$83K Sell
10,670
-318
-3% -$2.73K ﹤0.01% 862
2023
Q2 		$90K Buy
10,988
+1,910
+21% +$16.6K ﹤0.01% 804
2023
Q1 		$66K Sell
9,078
-117
-1% -$1.04K ﹤0.01% 827
2022
Q4 		$82K Buy
9,195
+7,663
+500% +$84.1K ﹤0.01% 803
2022
Q3 		$19K Sell
1,532
-114
-7% -$1.78K ﹤0.01% 1038
2022
Q2 		$19K Buy
1,646
+833
+102% +$11.2K ﹤0.01% 979
2022
Q1 		$15K Buy
+813
New +$15.1K ﹤0.01% 1064

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

CI Investments Inc's EDIT Position: Q2 2024 in Review

CI Investments Inc sold out of Editas Medicine (EDIT) in Q2 2024, closing a stake of 11,222 shares — an estimated $83K sold.

CI Investments Inc first reported a position in EDIT in Q1 2022 and held it in 9 quarters. The position peaked at $114K in Q4 2023. 235 funds tracked by Wall St. Rank hold EDIT as of Q2 2024.

  • CI Investments Inc reported no remaining Editas Medicine position as of Q2 2024 after selling out during the quarter.
  • CI Investments Inc sold 11,222 Editas Medicine shares in Q2 2024, an estimated $83K.
  • CI Investments Inc first reported a position in Editas Medicine in Q1 2022 and held it in 9 quarters.
  • CI Investments Inc's Editas Medicine position peaked at $114K in Q4 2023.
  • 235 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2024.

Based on CI Investments Inc's 13F filing for Q2 2024, filed 12 Aug 2024.